Anthrogen
AI biology research lab developing programmable molecular tools and protein models for biological research and intervention
Highlights
- New on EvolcAdded 2026-11-14
About Anthrogen
Anthrogen is an AI research lab in biology that develops programmable molecular tools and trains large protein models using internally generated data. Its research includes protein modeling and token-mixing methods tested across text, DNA and protein experiments.
Anthrogen is based in San Francisco, where its open roles span research, biology, engineering and operations.
Product: Programmable molecular tools and protein models developed through AI research in biology.
Jobs at Anthrogen
Open roles at Anthrogen in the Americas (3)
United States 3. From Anthrogen's careers page or applicant tracking system; each role links to the employer.
- <your-role-here /> · San Francisco, United States
- Founding Operator · San Francisco, United States
- Member of Platform Science (Research Scientist) · San Francisco, United States
More biotech & pharma companies
Arcaea
Biotechnology research and beauty product development for the beauty industry and consumersNew on EvolcArkeabio
Develops a methane-reducing vaccine for cattle to cut livestock emissions for farmers and food producersNew on EvolcAscendis Pharma
Biopharmaceutical therapies for patients with rare endocrine diseases and other medical needsAsimov
Genetic design software, engineered cells and DNA tools for biotechnology and therapeutics developersNew on EvolcAvalyn Pharma
Clinical-stage biopharma developing inhaled drugs for rare lung diseases such as pulmonary fibrosisNew on EvolcAxiom
AI drug-discovery platform that helps pharmaceutical scientists predict and mitigate toxicity before clinical developmentNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Hosting
- VercelHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-vercel-id
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
